RASSF6
Ras association domain-containing protein 6
Also known as: RASF6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZTQ3
- Gene
- RASSF6
- Ensembl
- ENSG00000169435
- Chromosome
- 4
- Canonical length
- 369 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
This gene encodes a member of the Ras-association domain family (RASSF). Members of this family form the core of a highly conserved tumor suppressor network, the Salvador-Warts-Hippo (SWH) pathway. The protein encoded by this gene is a Ras effector protein that induces apoptosis. A genomic region containing this gene has been linked to susceptibility to viral bronchiolitis. Alternative splicing results in multiple transcript variants and protein isoforms. [provided by RefSeq, Jul 2012]
Canonical amino-acid sequenceUniProt
369 residues, UniProt reviewed canonical sequence.
>Q6ZTQ3|RASSF6
1 MLWEETGAAP APARASDLPY RISSDHLKKE EKMTMMAHQY PSWIFINEKT FITREQLNSL
61 LKTYNIFYEN QKNLHILYGE TEDGKLIVEG MLDIFWGVKR PIQLKIQDEK PFSSFTSMKS
121 SDVFSSKGMT RWGEFDDLYR ISELDRTQIP MSEKRNSQED YLSYHSNTLK PHAKDEPDSP
181 VLYRTMSEAA LVRKRMKPLM MDRKERQKNR ASINGHFYNH ETSIFIPAFE SETKVRVNSN
241 MRTEEVIKQL LQKFKIENSP QDFALHIIFA TGEQRRLKKT DIPLLQRLLQ GPSEKNARIF
301 LMDKDAEEIS SDVAQYINFH FSLLESILQR LNEEEKREIQ RIVTKFNKEK AIILKCLQNK
361 LVIKTETTVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RASSF6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- stomach: 33 nTPM
- thymus: 29 nTPM
- pancreas: 16 nTPM
- rectum: 12 nTPM
- small intestine: 12 nTPM
- colon: 11 nTPM
Single-cell type
- tuft cells: 1,015 nCPM
- foveolar cells: 422 nCPM
- respiratory basal cells: 327 nCPM
- respiratory ionocytes: 307 nCPM
- breast lactating cells: 250 nCPM
- prostatic hillock cells: 246 nCPM
Immune cell
- memory B-cell: 2.7 nTPM
- naive B-cell: 0.3 nTPM
- memory CD4 T-cell: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- choroid plexus: 11 nTPM
- midbrain: 2.2 nTPM
- hypothalamus: 2 nTPM
- cerebral cortex: 1 nTPM
- hippocampal formation: 0.8 nTPM
- medulla oblongata: 0.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.93
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.19
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Protein domainsUniProt · Pfam · InterPro
- Ras-associating domain
- SARAH domain
- Ubiquitin-like domain superfamily
- Ras association domain-containing protein 1-6
- Ras association (RalGDS/AF-6) domain
- Novel Ras effector 1 C-terminal SARAH (Sav/Rassf/Hpo) domain
- Ras-association domain-containing protein 6, C-terminal SARAH domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RASSF6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RASSF6 as an antibody target. Whether an autoantibody or antibody against RASSF6 could matter depends on whether native RASSF6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RASSF6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RASSF6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...